WSU-NHLdoi:10.1049/ree.1978.0085alternative type namesspace groupstructural factorscell parameterscell volumeinteraxial ratioatom sitesite multiplicityWyckoff lettersite symmetryThere is no abstract available for this article.Hans G. DrexlerThe Leukemia-Lymphoma Cell Line FactsBook...
背景描述 derived from the pleural effusion of a 41-year-old man with B-cell non-Hodgkin lymphoma (B-NHL, diffuse large cell lymphoma non-cleaved type, intermediate grade - transformed from follicular small cleaved cell, low grade) at the status of relapse/progressive disease in 1990; cell li...
背景描述derived from the pleural effusion of a 41-year-old man with B-cell non-Hodgkin lymphoma (B-NHL, diffuse large cell lymphoma non-cleaved type, intermediate grade - transformed from follicular small cleaved cell, low grade) at the status of relapse/progressive disease in 1990; cell line...
化学名:WSU-NHL 别名: WSU-NHL CAS番号: 分子式: 分子量:0 EINECS: Mol File:Mol File Browse by Nationality Suppliers JAPAN suppliers China (1) Member (1) All (1) Eninquiry Recommend You Select Member Companies. 名前: DSMZ-German Collection of Microorganisms and Cell Cultures GmbH 電話...
WSU-NHL The Leukemia-Lymphoma Cell Line FactsBook 2001, Pages 284-285 Purchase options CorporateFor R&D professionals working in corporate organizations. Academic and personalFor academic or personal use only. Looking for a customized option? Contact sales for special pricing for your organizationContact...
Targeting B-Cell Malignancies With Anti-CD20-Interleukin-21 Fusokine The anti-CD20 antibody rituximab has revolutionized the treatment for B cell non-Hodgkin lymphomas (NHLs). However, rituximab has limited effectiveness as a single agent in some NHL subtypes and its clinical efficacy is compromised...